Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ackermann

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|July 17, 1999
Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridizationI Okamoto, H Pirc-Danoewinata, J Ackermann, et al.
Leukemia|November 11, 2006
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletionV Sagaster, H Ludwig, H Kaufmann, et al.
Annals of Hematology|July 28, 2001
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myelomaN Worel, H Greinix, J Ackermann, et al.
AJR. American Journal of Roentgenology|June 1, 1989
SPECT of the peritoneal cavity: method for delineating intraperitoneal fluid distributionR L Wahl, J Gyves, B H Gross, et al.
Medical Problems of Performing Artists|June 2, 2019
Health Education Literacy and Accessibility for Musicians: A Global Approach. Report from the Worldwide Universities Network ProjectVera A Baadjou, Suzanne I Wijsman, Jane Ginsborg, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design and synthesis of potent and highly selective thrombin inhibitorsK Hilpert, J Ackermann, D W Banner, et al.
Nucleic Acid Therapeutics|April 15, 2020
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin AmyloidosisRosie Z Yu, Jon W Collins, Shannon Hall, et al.
European Radiology|June 3, 2020
Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platformIsabella Fornacon-Wood, Hitesh Mistry, Christoph J Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresH Kaufmann, J Ackermann, H Greinix, et al.
Leukemia & Lymphoma|March 8, 2000
Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasiaN Zojer, J G Meran, M Vesely, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|July 17, 1999
Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridizationI Okamoto, H Pirc-Danoewinata, J Ackermann, et al.
Leukemia|November 11, 2006
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletionV Sagaster, H Ludwig, H Kaufmann, et al.
Annals of Hematology|July 28, 2001
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myelomaN Worel, H Greinix, J Ackermann, et al.
AJR. American Journal of Roentgenology|June 1, 1989
SPECT of the peritoneal cavity: method for delineating intraperitoneal fluid distributionR L Wahl, J Gyves, B H Gross, et al.
Medical Problems of Performing Artists|June 2, 2019
Health Education Literacy and Accessibility for Musicians: A Global Approach. Report from the Worldwide Universities Network ProjectVera A Baadjou, Suzanne I Wijsman, Jane Ginsborg, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design and synthesis of potent and highly selective thrombin inhibitorsK Hilpert, J Ackermann, D W Banner, et al.
Nucleic Acid Therapeutics|April 15, 2020
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin AmyloidosisRosie Z Yu, Jon W Collins, Shannon Hall, et al.
European Radiology|June 3, 2020
Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platformIsabella Fornacon-Wood, Hitesh Mistry, Christoph J Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresH Kaufmann, J Ackermann, H Greinix, et al.
Leukemia & Lymphoma|March 8, 2000
Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasiaN Zojer, J G Meran, M Vesely, et al.
Pageof 22